Real World Comparison of Rivaroxaban and Warfarin in Korean Patients with Atrial Fibrillation: Propensity Matching Cohort Analysis

Rivaroxaban has emerged as a potential alternative to warfarin for the prevention of thromboembolism in patients with atrial fibrillation (AF). However, there has been concern for the risk of major bleeding, especially in Asian patients. We investigated the efficacy and safety of rivaroxaban compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hyung Ki, Lee, Ki Hong, Park, Hyung Wook, Yoon, Nam Sik, Kim, Min Chul, Lee, Nuri, Kim, Ji Sung, Ahn, Youngkeun, Jeong, Myung Ho, Park, Jong Chun, Cho, Jeong Gwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351319/
https://www.ncbi.nlm.nih.gov/pubmed/30740341
http://dx.doi.org/10.4068/cmj.2019.55.1.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351319/
https://www.ncbi.nlm.nih.gov/pubmed/30740341
http://dx.doi.org/10.4068/cmj.2019.55.1.54

Ejemplares similares